From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy for Resistant Ovarian Cancer

A first-of-its-kind combination therapy could make treatment more effective by attacking hard-to-treat cancer from two angles.